CN102648975A - Traditional Chinese medicine for treating primary thrombocytopenic purpura - Google Patents
Traditional Chinese medicine for treating primary thrombocytopenic purpura Download PDFInfo
- Publication number
- CN102648975A CN102648975A CN2011103780783A CN201110378078A CN102648975A CN 102648975 A CN102648975 A CN 102648975A CN 2011103780783 A CN2011103780783 A CN 2011103780783A CN 201110378078 A CN201110378078 A CN 201110378078A CN 102648975 A CN102648975 A CN 102648975A
- Authority
- CN
- China
- Prior art keywords
- medicine
- thrombocytopenic purpura
- gram
- chinese medicine
- bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine for treating primary thrombocytopenic purpura. The invention aims at the goals that according to the treatment principle and the pathogenesis recognition on the primary thrombocytopenic purpura in the traditional medicine of the Chinese medicine, natural Chinese medicinal herbs with the functions of promoting blood circulation to remove blood stasis, stopping bleeding and enriching blood are screened, and the effects of the natural Chinese medicinal herbs are realized according to the traditional Chinese medicine theory composition. The medicine disclosed by the invention is prepared form the following ingredients: achyranthes root, ginkgo leaf, red flower, radix curcumae, red paeonia, pseudo-ginseng, Chinese date and pollen typhae. All of the ingredients are uniformly mixed and crushed into 150-mesh fine powder, the fine powder is subjected to split charging into bags, and 6g of medicine powder is filled in each bag. The medicine is taken after meals, and one bag is taken in each day in twice after being mixed with water.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of Chinese medicine of treating idiopathic thrombocytopenic purpura, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology idiopathic thrombocytopenic purpura is a species specificity autoimmune disease; Be one of clinical common hemorrhage, be characterized in having platelet antibody in the blood circulation, make platelet destruction too much; Cause skin petechia ecchymosis, mucosa and visceral hemorrhage; Severe patient can cause intracranial hemorrhage and threat to life is a kind of disease of serious harm health, and western medical treatment should disease be main with hormone (like prednisone) at present; But the side effect of hormone is huge, can bring other severe complications (as occurring disease such as hypoadrenocorticism behind the hormone of stopping using) to human body.This disease belongs to motherland's medical science " blood disorder " category, the blood circulation promoting and blood stasis dispelling of Chinese medicine, hemostasis hemopoietic treatment should disease aspect tool use great potential, so invent that a kind of Chinese medicine of treating idiopathic thrombocytopenic purpura treats should disease.
It is the medicine of the treatment idiopathic thrombocytopenic purpura of the rule of treatment with blood circulation promoting and blood stasis dispelling, hemostasis hemopoietic that summary of the invention the purpose of this invention is to provide a kind of, to overcome the deficiency of prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's medical tradition medical science idiopathic thrombocytopenic purpura; With reference to modern pharmacological research; Therefrom filter out the natural Chinese medicinal herb of blood circulation promoting and blood stasis dispelling, hemostasis hemopoietic,, it is played a role by the theory of Chinese medical science prescription.
Medicine of the present invention is processed by following component:
Radix Achyranthis Bidentatae 12 gram Folium Ginkgos 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Fructus Jujubaes 15 gram Pollen Typhaes 15 grams
Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.One after each meal, is used mixing in water for oral taking at twice at one bag of every day.
Medicine of the present invention is a Chinese medicine preparation, and is theoretical according to traditional Chinese medical science prescription, select medicine rationally, blood circulation promoting and blood stasis dispelling, hemostasis hemopoietic, treating both the principal and secondary aspects of a disease.Medicine of the present invention, warp is the clinical observation patient for many years, and evident in efficacy, the idiopathic thrombocytopenic purpura patient that a variety of causes is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
1, to select natural plant for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment idiopathic thrombocytopenic purpura of the medicine of respectively distinguishing the flavor of, and no chemicals is harmless to human non-toxic, has no side effect, and is safe and reliable.
2, the present invention is a powder, and effective ingredient scatters and disappears few, and curative effect is high, and is cheap, taking convenience, no any discomfort disease.
3, medicine of the present invention is obvious to the idiopathic thrombocytopenic purpura curative effect.
4, clinical drug of the present invention is observed, the medicine of instead other treatment idiopathic thrombocytopenic purpura.
For showing the therapeutic effect of medicine of the present invention to idiopathic thrombocytopenic purpura; The present invention is through the clinical observation of 88 routine idiopathic thrombocytopenic purpura patient systems; And select medical history, the state of an illness, age and idiopathic thrombocytopenic purpura patient 86 examples suitable to organize as a comparison with traditional therapy; Age 16-62 year, course of disease 1-6; Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 3 months, checks after half a year, does not have recurrence and is produce effects, and the state of an illness is clearly better to effectively, and the state of an illness is clearly better and is good effect, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Instructions of taking: every packed medicated powder 6 grams.One after each meal, is used mixing in water for oral taking at twice at one bag of every day.Clinical comparison result sees table 1.
Table 1: take medicine of the present invention and take the observation of curative effect of conventional medicine to the idiopathic thrombocytopenic purpura patient.
Two groups of curative effects comparisons of table 1 (example, %)
| Group | n | Produce effects | The good effect | Effectively | Invalid | Total significant figure |
| Experimental group | 88 | 58(65.9) | 20(22.7) | 8(9.1) | 20(2.3) | 86(97.7) |
| Matched group | 86 | 38(44.2) | 18(20.9) | 14(16.3) | 16(18.6) | 70(81.4) |
Annotate: curative effect relatively adopts statistical method, and enumeration data adopts X
2Check, two groups of effective percentage compare P＜0.01
Can find out that from table 1 medicine of the present invention is obtained 58 examples that have of significant curative effect to 88 routine idiopathic thrombocytopenic purpura patients, accounts for 69.5%, and 20 examples that have of good result are arranged, and accounts for 22.7%, and 8 examples are effectively arranged, and accounts for 9.1%; Total effective rate reaches 97.7%.
The specific embodiment
Choose raw material by following proportioning:
Radix Achyranthis Bidentatae 12 gram Folium Ginkgos 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Fructus Jujubaes 15 gram Pollen Typhaes 15 grams; Above-mentioned each component mix homogeneously is ground into 150 order fine powders, is distributed into bag, every packed medicated powder 6 grams.
Claims (1)
1. treating a kind of Chinese medicine of treating idiopathic thrombocytopenic purpura is the powder of being processed by the following weight proportion raw material: Radix Achyranthis Bidentatae 12 gram Folium Ginkgos 16 gram Flos Carthamis 12 gram Radix Curcumaes 18 gram Radix Paeoniae Rubra 15 gram Radix Notoginseng 10 gram Fructus Jujubaes 15 gram Pollen Typhaes 15 grams; Above-mentioned each component mix homogeneously is ground into 150 order fine powders; Be distributed into bag, every packed medicated powder 6 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103780783A CN102648975A (en) | 2011-11-10 | 2011-11-10 | Traditional Chinese medicine for treating primary thrombocytopenic purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103780783A CN102648975A (en) | 2011-11-10 | 2011-11-10 | Traditional Chinese medicine for treating primary thrombocytopenic purpura |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102648975A true CN102648975A (en) | 2012-08-29 |
Family
ID=46691206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103780783A Pending CN102648975A (en) | 2011-11-10 | 2011-11-10 | Traditional Chinese medicine for treating primary thrombocytopenic purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102648975A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1111521A (en) * | 1994-12-27 | 1995-11-15 | 赵翠兰 | Traditional Chinese medicine for curing hemorrhagic diseases and preparation |
| CN1839953A (en) * | 2005-03-31 | 2006-10-04 | 张涌川 | Medicine for treating idiopathy thrombocytopenia peliosis |
| KR100796014B1 (en) * | 2002-03-20 | 2008-01-21 | 박준희 | Hemostatic Extraction Method Using Samchil |
| CN101810835A (en) * | 2010-05-26 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating purpura and preparation method thereof |
| KR20110042772A (en) * | 2009-10-20 | 2011-04-27 | 김정숙 | The health foods for antithrombotic effectiveness containing extracts of crude drug |
| CN102048888A (en) * | 2009-10-27 | 2011-05-11 | 菲伯纳生物医药有限责任公司 | Pharmaceutical composition for eliminating thrombus |
-
2011
- 2011-11-10 CN CN2011103780783A patent/CN102648975A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1111521A (en) * | 1994-12-27 | 1995-11-15 | 赵翠兰 | Traditional Chinese medicine for curing hemorrhagic diseases and preparation |
| KR100796014B1 (en) * | 2002-03-20 | 2008-01-21 | 박준희 | Hemostatic Extraction Method Using Samchil |
| CN1839953A (en) * | 2005-03-31 | 2006-10-04 | 张涌川 | Medicine for treating idiopathy thrombocytopenia peliosis |
| KR20110042772A (en) * | 2009-10-20 | 2011-04-27 | 김정숙 | The health foods for antithrombotic effectiveness containing extracts of crude drug |
| CN102048888A (en) * | 2009-10-27 | 2011-05-11 | 菲伯纳生物医药有限责任公司 | Pharmaceutical composition for eliminating thrombus |
| CN101810835A (en) * | 2010-05-26 | 2010-08-25 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating purpura and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
| CN101785844A (en) | Traditional Chinese medicine combination and preparation method thereof for dysentery treatment | |
| CN101708281B (en) | Chinese medicinal preparation for nourishing heart and tranquilizing mind and preparation method thereof | |
| CN104940485A (en) | Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof | |
| CN103007237B (en) | Medicine for treating idiopathic thrombocytopenic purpura (ITP) | |
| CN103251880B (en) | Pharmaceutical composition for treating tumor and preparation method thereof | |
| CN104800799B (en) | It is a kind of to treat Chinese medicine of the endometrial thickness with ovarian cyst | |
| CN102526613B (en) | Medicament for treating allergic cutaneous vasculitis | |
| CN105963501A (en) | Method for preparing traditional Chinese medicine composition for treating infantile asthma | |
| CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
| CN102648975A (en) | Traditional Chinese medicine for treating primary thrombocytopenic purpura | |
| CN102526622B (en) | Medicine for treating knee-joint bursitis | |
| CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura | |
| CN103070992B (en) | Medicine for treating high myopia macular hemorrhages | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN102671032B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients | |
| CN102526610A (en) | Traditional Chinese medicine for curing multiple takayasu arteritis | |
| CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis | |
| CN104606553B (en) | A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal | |
| CN102406875A (en) | Drug for treating endometriosis interna | |
| CN104587280B (en) | A kind of medicament for the treatment of Rickets In Infants And Children | |
| CN102552569B (en) | Medicine for treating renal artery type arteritis | |
| CN102430095A (en) | Medicine for treating lung cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120829 |